ESAB Reports Upsizing And Pricing Of Its 6.25% Senior Notes Due 2029
$ESAB
Industrial Machinery/Components
Industrials
ESAB Reports Upsizing And Pricing Of Its 6.25% Senior Notes Due 2029
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/18/2024 | $138.00 → $130.00 | Buy → Hold | Stifel |
| 11/13/2024 | $102.00 → $122.00 | In-line → Underperform | Evercore ISI |
| 6/20/2024 | $115.00 | Outperform | Oppenheimer |
| 3/18/2024 | $111.00 → $125.00 | Neutral → Overweight | JP Morgan |
| 9/27/2023 | $78.00 | Neutral | UBS |
| 9/18/2023 | $61.00 → $89.00 | Neutral → Buy | BofA Securities |
| 7/18/2023 | $70.00 → $74.00 | Overweight → Neutral | JP Morgan |
| 7/14/2023 | $75.00 | In-line | Evercore ISI |
144 - ESAB Corp (0001877322) (Subject)
144 - ESAB Corp (0001877322) (Subject)
10-Q - ESAB Corp (0001877322) (Filer)
Stifel downgraded ESAB Corp. from Buy to Hold and set a new price target of $130.00 from $138.00 previously
Evercore ISI downgraded ESAB Corp. from In-line to Underperform and set a new price target of $122.00 from $102.00 previously
Oppenheimer initiated coverage of ESAB Corp. with a rating of Outperform and set a new price target of $115.00
Mass legal action claims South Carolina importer covered up deadly effects of asbestos, caused widespread fatal health consequences across the US More than 150 plaintiffs have filed suit against Cape, PLC, its subsidiaries and global affiliates including Anglo American (OTCQX: NGLOY), De Beer Group PLC (OTCQX: AAUKF), and ESAB Corp. (NYSE: ESAB), which imported and distributed carcinogenic asbestos in the United States for decades. "Cape and its related entities, by its own admission, sold more than 95% of the type of asbestos commonly used in industry and on U.S. Navy ships for decades. That asbestos is responsible for untold death and despair among the workers of South Carolina and th
Positive core organic growth New equipment gaining traction EBX driving record margin Raised mid-point of 2024 outlook ESAB Corporation ("ESAB" or the "Company") (NYSE:ESAB), a focused premier industrial compounder, today announced financial results for the third quarter of 2024. ESAB reported third quarter sales of $673 million, a decrease of 1% on a reported basis or an increase of 1% on a core organic growth basis before acquisitions and currency translation, as compared to the prior year. ESAB also reported third quarter net income from continuing operations attributable to ESAB of $69 million or $1.13 diluted earnings per share and core adjusted net income of $77 million or $
A South Carolina court has set a trial date of Feb. 3, 2025, to determine whether Anglo-American, PLC (OTCQX:NGLOY), ESAB Corp. (NYSE:ESAB) and billionaire businessman Mohed Altrad, among others, can be held responsible for billions of dollars of liabilities stemming from asbestos that Cape Asbestos sent to companies in the United States and South Carolina for decades. A court-appointed receiver in June 2023 filed suit against numerous entities including Anglo American and ESAB for various causes of action, including unjust enrichment and that the defendants were responsible for the actions of Cape. The receiver was appointed after Cape failed to answer the underlying lawsuit brought by th
4 - ESAB Corp (0001877322) (Issuer)
4 - ESAB Corp (0001877322) (Issuer)
4 - ESAB Corp (0001877322) (Issuer)
Stifel analyst Nathan Jones maintains ESAB (NYSE:ESAB) with a Buy and lowers the price target from $130 to $120.
Oppenheimer analyst Bryan Blair initiates coverage on ESAB (NYSE:ESAB) with a Outperform rating and announces Price Target of $115.
Positive core organic growth New equipment gaining traction EBX driving record margin Raised mid-point of 2024 outlook ESAB Corporation ("ESAB" or the "Company") (NYSE:ESAB), a focused premier industrial compounder, today announced financial results for the third quarter of 2024. ESAB reported third quarter sales of $673 million, a decrease of 1% on a reported basis or an increase of 1% on a core organic growth basis before acquisitions and currency translation, as compared to the prior year. ESAB also reported third quarter net income from continuing operations attributable to ESAB of $69 million or $1.13 diluted earnings per share and core adjusted net income of $77 million or $
ESAB Corporation ("ESAB" or the "Company") (NYSE:ESAB), a focused premier industrial compounder, announced today that it will issue a press release providing financial results for the third quarter of 2024 on the morning of Tuesday, October 29, 2024. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-888-550-5302 (U.S. callers) and +1-646-960-0685 (International callers) and referencing the conference ID number 4669992 and through webcast via ESAB's website www.ESABcorporation.com under the "Investors" section. ESAB's financial results press release and supplemental information referenc
ESAB Corporation ("ESAB" or the "Company") (NYSE:ESAB), a focused premier industrial compounder, announced today that its Board of Directors has declared a quarterly cash dividend of $0.08 per share of the Company's common stock. The dividend is payable on October 11, 2024 to shareholders of record as of September 27, 2024. About ESAB Corporation Founded in 1904, ESAB Corporation is a focused premier industrial compounder. The Company's rich history of innovative products, workflow solutions and its business system ESAB Business Excellence (EBX), enables the Company's purpose of Shaping the world we imagine TM. ESAB Corporation is based in North Bethesda, Maryland and employs approximatel
SC 13G/A - ESAB Corp (0001877322) (Subject)
SC 13G/A - ESAB Corp (0001877322) (Subject)
SC 13G/A - ESAB Corp (0001877322) (Subject)